Experimental evolution of Saccharomyces cerevisiae for caffeine tolerance alters multidrug resistance and target of rapamycin signaling pathways
G3: Genes, Genomes, Genetics · 04.09.2024 · 14 (9)
DOI: 10.1093/g3journal/jkae148 ↗Kurz gefasst
Fachartikel in der Zeitschrift G3: Genes, Genomes, Genetics, online erschienen am 11.07.2024. Verfasst von Renee C Geck und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA. Hauptthemen laut MEDLINE: Caffeine, Mutation, Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NHGRI NIH HHS, National Science Foundation.
Abstract (Originalsprache)
Caffeine is a natural compound that inhibits the major cellular signaling regulator target of rapamycin (TOR), leading to widespread effects including growth inhibition. Saccharomyces cerevisiae yeast can adapt to tolerate high concentrations of caffeine in coffee and cacao fermentations and in experimental systems. While many factors affecting caffeine tolerance and TOR signaling have been identified, further characterization of their interactions and regulation remain to be studied. We used experimental evolution of S. cerevisiae to study the genetic contributions to caffeine tolerance in yeast, through a collaboration between high school students evolving yeast populations coupled with further research exploration in university labs. We identified multiple evolved yeast populations with mutations in PDR1 and PDR5, which contribute to multidrug resistance, and showed that gain-of-function mutations in multidrug resistance family transcription factors Pdr1, Pdr3, and Yrr1 differentially contribute to caffeine tolerance. We also identified loss-of-function mutations in TOR effectors Sit4, Sky1, and Tip41 and showed that these mutations contribute to caffeine tolerance. These findings support the importance of both the multidrug resistance family and TOR signaling in caffeine tolerance and can inform future exploration of networks affected by caffeine and other TOR inhibitors in model systems and industrial applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
- Troy High School, Troy, MI 48098, USA.
- Foster High School, Tukwila, WA 98168, USA.
- Program in Biology, Loras College, Dubuque, IA 52001, USA.
ORCID-Profile: Renee C Geck, Naomi G Moresi, Leah M Anderson, Timothy R Renz, Matthew Bryce Taylor, Maitreya J Dunham
Förderung
- NIGMS NIH HHS
- NHGRI NIH HHS
- National Science Foundation
- National Human Genome Research Institute
- Momental Foundation
- National Institute of General Medical Sciences
Zitieren
APA
Geck, R. C., Moresi, N. G., Anderson, L. M., yEvo Students, Brewer, R., Renz, T. R., Taylor, M. B., & Dunham, M. J. (2024). Experimental evolution of Saccharomyces cerevisiae for caffeine tolerance alters multidrug resistance and target of rapamycin signaling pathways. G3: Genes, Genomes, Genetics, 14(9). https://doi.org/10.1093/g3journal/jkae148
Vancouver
Geck RC, Moresi NG, Anderson LM, yEvo Students, Brewer R, Renz TR, et al. Experimental evolution of Saccharomyces cerevisiae for caffeine tolerance alters multidrug resistance and target of rapamycin signaling pathways. G3: Genes, Genomes, Genetics. 2024;14(9). doi:10.1093/g3journal/jkae148
BibTeX
@article{Geck2024,
author = {Geck, Renee C and Moresi, Naomi G and Anderson, Leah M and yEvo Students, yEvo Students and Brewer, Rebecca and Renz, Timothy R and Taylor, Matthew Bryce and Dunham, Maitreya J},
title = {Experimental evolution of Saccharomyces cerevisiae for caffeine tolerance alters multidrug resistance and target of rapamycin signaling pathways},
journal = {G3: Genes, Genomes, Genetics},
year = {2024},
volume = {14},
number = {9},
doi = {10.1093/g3journal/jkae148}
}
EUVIMED